Patrick Soon-Shiong

Patrick Soon-Shiong (#395)

My quest was and is to improve the quality of life through science. That is what drove me then, and that is what is driving me now.

$ 9 B
Pharmaceuticals
United States
M
73 Years

About Me

Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer. He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion. He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016. He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers. He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018. In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Patrick Soon-Shiong’s rise and global influence.

#308 Billionaires (2026)
#270 Forbes 400 (2025)

Wealth Growth

Net Worth Growth Over Time

Tracking Patrick Soon-Shiong’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $8.9B (May 4, 2026)